An Emory University program has been awarded $2 million toward optimizing the effectiveness of U.S. newborn screening programs, which…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Researchers have uncovered a mechanism by which Pseudomonas aeruginosa and Aspergillus fumigatus…
Families in the U.S. living with cystic fibrosis (CF) who’ve been affected by food insecurity feel that…
A disease found in dogs where abnormally thick mucus accumulates in the gallbladder — called a mucocele — is characterized…
Lung transplant rates among people with cystic fibrosis (CF) in the U.S. have declined dramatically since the approval of…
Nearly two-thirds of cystic fibrosis (CF) patients in a study showed signs of type 2 inflammation, which was associated…
Additional mutations in the SLC26A9 gene among cystic fibrosis (CF) patients with two copies of F508del — the most…
A lung-targeted gene-editing therapy designed using technology from ReCode Therapeutics was able to successfully correct a disease-causing CFTR gene…
Exposure in utero to the cystic fibrosis (CF) medication Trikafta (elexacaftor/tezacaftor/ivacaftor) didn’t appear to negatively affect organ development…
A lung transplant can be lifesaving for children with cystic fibrosis (CF) admitted for respiratory failure to a pediatric…